Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.

Patient being given a vaccination by a healthcare professional

Obesity was flagged as a risk factor for severe COVID-19 early in the global pandemic. The UK’s vaccine programme in 2021 gave priority to people with a BMI over 40, categorising them as a high-risk group. However, prior to this study, little was known about the effectiveness of the COVID-19 vaccines for overweight people and those with obesity.  

The new study, led by researchers at the University of Oxford, also found that vaccinated people with underweight or overweight are at greater risk of hospitalisation and death compared with vaccinated people of healthy weight. This replicates the findings seen in a previous analysis before the vaccination programme began. Moreover, the findings suggest that underweight people were less likely to be vaccinated, although the reasons for this are not well understood. 

Read the full story on the Nuffield Department of Primary Care Health Sciences website

The study and its findings are also discussed in this The Conversation article

Similar stories

Misophonia: nearly one in five UK adults have the condition causing extreme reactions to certain sounds

Many of us have sounds that we find to be annoying. But for some people, certain sounds actually trigger extreme reactions.

Any type of hormonal contraceptive may increase risk of breast cancer

An analysis of data by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.